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Abbreviations
CerPCho  Sphingomyelin
ESI  Electrospray ionization
HILIC Hydrophilic interaction liquid chromatography
LysoPtdCho  Lysophosphatidylcholine
PAF  Platelet-activating factor
PCA  Principal component analysis




QTOF  Quadrupole time of flight mass spectrometer
TLC  Thin layer chromatography
UPLC Ultra high performance liquid chromatography
Introduction
Lyme disease is a human infection transmitted by ticks 
(Ixodidae) and caused by the spirochete Borrelia burgdor-
feri. A dramatic increase in the number of cases of Lyme 
disease in Europe has been reported in the past two decades 
(200,000 new cases/year) and the United States (15,000–
20,000 new cases/year), and this number continues to rise. 
The most dangerous manifestation of Lyme disease is 
neuroborreliosis, which is associated with infection of the 
central nervous system. Previously, we showed enhanced 
phospholipid (PL) peroxidation and decreased phospholi-
pase A2 (PLA2) activity, the main enzyme releasing peroxi-
dation products, during neuroborreliosis [1]. Despite these 
findings, the pathogenesis of neuroborreliosis has still not 
been fully determined. However, there are indications that 
PL and their metabolites participate in the inflammatory 
response in Lyme disease [2, 3]. It is known that some PL 
species such as lyso-phosphatidylcholines (LysoPtdCho), 
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phosphatidyethanolamines (PtdEtn), phosphatidylcholines 
(PtdCho), phosphatidylinositol (PtdIns), and sphingolipids 
(CerPCho) are involved in the development of inflamma-
tory diseases such as rheumatoid arthritis, pancreatic can-
cer, and ovarian cancer [4–6]. To date there are no pub-
lished reports that have focused on the profiles of the main 
PL species in plasma from patients with neuroborreliosis. 
This data might lead to the identification of altered meta-
bolic pathways, and be useful for monitoring pharmaco-
therapy. Therefore, the aim of this study was to extend our 
knowledge of PL participation in the development of neu-
roborreliosis using a lipidomic approach.
Materials and Methods
Chemicals
All solvents used were of LC–MS grade. All chemicals 
were purchased from Sigma-Aldrich (St. Louis, MO, USA) 
and had greater than 95% purity. PL internal standards 
were purchased from Avanti Polar Lipids.
Biological Material
We obtained plasma samples from neuroborreliosis patients 
and healthy subjects collected in the Department of Infec-
tious Diseases and Neuroinfections, Medical University of 
Bialystok (Poland). The samples were collected from eight 
patients with neuroborreliosis (three female and five male) 
with an average age of 48 years (range 21–83). The control 
group consisted of eight healthy subjects (three female and 
five male), with an average age of 47 years (range 22–72).
The diagnosis of neuroborreliosis was confirmed by epi-
demiological anamnesis. Fifty percent of the neuroborrelio-
sis patients reported previous tick bites, clinical manifesta-
tions of Bannwarth’s syndrome, lymphocytic meningitis 
with or without nerves paresis, and serological detection 
of anti-B. burgdorferi IgM and IgG antibodies in enzyme-
linked immunosorbent assays (ELISA; Borrelia recombi-
nant IgG and IgM High Sensitivity, Biomedica, Austria). 
In all cases, the ELISA results were confirmed by western 
blotting. Additionally, IgM and IgG immunoblot tests were 
performed (Virotech, Germany) to estimate intrathecal syn-
thesis of antibodies in cerebrospinal fluid (CSF).
All neuroborreliosis patients had serum anti-B. burg-
dorferi antibodies, with mean titres for IgM and IgG of 
24 ± 19 BBU/ml and 55 ± 23 BBU/ml, respectively. Three 
patients (37%) had intrathecal synthesis of IgM antibodies, 
five (62%) had intrathecal synthesis of IgG antibodies, and 
two patients (25%) had both in their CSF. Based on these 
criteria we diagnosed a definitive clinical picture, lym-
phocytary pleocytosis in CSF, intrathecal immunoglobulin 
synthesis and probable clinical history and at least one of 
the following findings: lymphocytary pleocytosis in CSF, 
erythema migrans >5 cm in diameter, or prompt clinical 
response to antibiotic treatment. In all patients tick-borne 
encephalitis was excluded based on serological tests on 
serum and CSF.
The exclusion criteria for both groups were as follows: 
pregnancy, lack of written consent, or recent treatment 
with nonsteroidal anti-inflammatory drugs, steroids, or oral 
contraceptives. In the control group, there was no history 
of other diseases which could influence increased PL oxi-
dation, e.g., arthritis of any etiology. Patients and healthy 
subjects with alcohol abuse and heavy smokers were also 
excluded from the study. The study had approval from the 
Local Bioethics Committee at the Medical University of 
Bialystok, and written informed consent was obtained from 
all patients.
Blood was collected from all participants into ethylen-
ediaminetetraacetic acid tubes and centrifuged at 2000×g 
(4 °C) to obtain the plasma.
Lipid Extraction
Total lipids from all plasma samples were extracted using 
a modified Folch method [7]. In brief, 1.5 ml of ice-cold 
methanol was added to each 200 µl of plasma sample and 
vortexed thoroughly. Then, 3 ml of chloroform was added, 
vortexed, and incubated on ice for 60 min. To induce phase 
separation, 1.25 ml ultra-pure Milli-Q water was added. 
After 10 min incubation on ice, samples were centrifuged 
at 2500×g for 10 min at room temperature to obtain the 
aqueous top and organic bottom phases from which lipids 
were obtained.
PL Quantification and Separation of PL Classes 
by Thin Layer Chromatography (TLC)
Silica gel TLC plates 20 × 20 cm (Merck, Darmstadt, Ger-
many) were used to separate the PL classes. First, plates 
were treated with 2.3% boric acid in ethanol. Then, 20 µl 
of 20–30 µg PL extract were seeded on the TLC plate and 
developed using a mixture of chloroform/ethanol/water/
triethylamine 35:30:7:35, v/v/v/v. PL spots were observed 
by exposure to primuline 50 µg/100 mL acetone:water, 
80:20, v/v, and visualized with a UV lamp at λ = 254 nm 
[9]. Identification of the different PL classes was performed 
by comparison with PL standards applied to the same plate. 
Estimation of the total amount of PL in total lipid extracts 
and in the spots after TLC separation was performed 
according to Bartlett and Lewis [8]. The relative abundance 
(%) of each PL class was calculated by relating the amount 
of phosphorous in each spot to the amount of total phos-
phorous in each plasma lipid extract.
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PL Profile Characterization by HILIC‑LC–MS
PL classes were separated by hydrophilic interaction liq-
uid chromatography (HILIC), performed on an Ultra high 
performance liquid chromatography (UPLC) system (Agi-
lent 1290; Agilent Technologies, Santa Clara, CA, USA) 
coupled to a quadrupole time of flight mass spectrometer 
(QTOF) (Agilent 6540; Agilent Technologies, Santa Clara, 
CA, USA). The characterization of PL classes and individ-
ual species within each class was achieved by data depend-
ent ESI–QTOF–MS/MS in negative mode with formation 
of [M-H]− for PtdIns and PtdEtn, and with formation of 
[M + OAc]− for PtdCho, LysoPtdCho, and CerPCho.
Mobile phase A consisted of 25% water, 50% acetoni-
trile, 25% v/v methanol with 10 mM ammonium acetate. 
Mobile phase B consisted of acetonitrile 60%, methanol 
40% with 10 mM ammonium acetate. Total PL samples 
(20 µg) were diluted in mobile phase B and 5 µl of the mix-
ture was introduced into an Ascentis Si HPLC Pore column 
15 cm × 1.0 mm, 3 µm (Sigma-Aldrich). The solvent gradi-
ent was programmed as follows: the gradient started with 0% 
of A, linearly increased to 100% over 20 min, held isocrati-
cally for 35 min, and returning to the initial conditions over 
5 min. The flow rate through the column was 40 µl/min.
ESI Agilent Dual AJS ESI conditions were as follows: 
electrospray voltage, −3.0 kV; capillary temperature, 
250 °C; sheath gas flow, 13 L/min. Parent scan spectra 
were acquired in the range of m/z 100–1500. Collision 
energy was fixed at 35 for MS/MS. Data acquisition was 
carried out with Mass Hunter data software version B0.6.0 
(Agilent Technologies, Santa Clara, CA, USA). An iso-
lation width of ~1.3 Da was used for the MS/MS experi-
ments. MS/MS was performed for each ion to identify and 
confirm their structure, according to the typical fragmen-
tation pathways [10]. Internal standards PtdCho 14:0/14:0, 
PtdIns 16:0/16:0, and PE 14:0/14:0, (Avanti Polar Lipids) 
were used to confirm the ion variations observed in the MS 
spectra according to Lipid Maps [11]. The relative abun-
dance of each ion was calculated by normalizing the area 
of each extracted ion chromatogram peak to the area of an 
internal standard.
Statistical Analysis
Means ± standard deviations (SD) were calculated for all 
data. The relative ion abundances obtained by HILIC-LC–
MS from the two groups of plasma extracts were analyzed 
using one-way analysis of variance (ANOVA) with Bonfer-
roni post hoc tests used to determine significant differences 
between samples. Differences were considered signifi-
cant if p < 0.05. Statistical analysis was performed using 
GraphPad Prism 5 for Windows version 5.0.1 (GraphPad 
Software, San Diego, CA, USA). Principal component 
analysis (PCA) classification of the data was performed 
using SIMCA-P + version 12.0.1 software (Umetrics, 
Umeå, Sweden). This was performed using data from the 
most abundant PL species in each class, following log 
transformation to achieve normal distribution of the data, 
followed by Pareto-scaling.
Results and Discussion
The pathology of many infectious diseases, including 
Lyme disease, is associated with altered PL metabolism. 
The composition of PL can be considered an index of the 
organism in health and disease, as well as an indicator of 
metabolic responses to pharmacotherapy [12]. TLC analy-
sis of plasma extracts confirmed that the most abundant 
PL class in all plasma samples was PtdCho, while CerP-
Cho, LysoPtdCho, PtdIns, and PtdEtn were less abundant 
(Fig. 1), which is the typical PL pattern for human plasma 
[13]. The results of PL quantification by phosphorous assay 
showed decreases of PtdCho in the plasma of neuroborre-
liosis patients compared with controls, while CerPCho and 
LysoPtdCho were significantly more abundant (Fig. 1).
The formation of LysoPtdCho species can occur as a 
result of oxidative degradation of PtdCho, as demonstrated 
by an increase of lipid peroxidation in plasma of neurobor-
reliosis patients in our previous work [1]. The decrease in 
plasma PtdCho may explain the increase in lipid peroxida-
tion found in those patients. The other PL classes (PtdIns 
and PtdEtn) were not significantly different in healthy 
subjects and patients. We then analyzed PL profiles using 
a HILIC-LC MS/MS approach, focusing on the four main 
classes: phosphatidylcholine, sphingomyelin, lysophos-
phatidylcholine, and phosphatidylethanolamine and 
phosphatidylinositol.
Fig. 1  Amount of plasma phospholipid per class in healthy sub-
jects and neuroborreliosis patients. Data obtained by colorimet-
ric assay preformed after TLC separation (values are mean ± SD 
***p < 0.001)
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Phosphatidylcholine
The most abundant PtdCho species observed in plasma [13] 
were identified by HILIC-LC–MS, and the fatty acyl chain 
compositions annotated. No significant differences in the 
relative abundance of PtdCho species were found between 
healthy subjects and neuroborreliosis patients (Fig. 2).
Sphingomyelin
The sphingomyelin profiles of all plasma extracts exam-
ined showed three major species, CerPCho d18:1/16:0, 
CerPCho d18:0/18:0, and CerPCho d18:1/24:1, observed 
as [M + OAc]− ions at m/z 761.5823, 791.4909, and 
871.6906, respectively (Fig. 3). LC–MS data analysis 
showed an increase in the relative abundance of CerPCho 
d18:1/24:1 and a decrease in the relative abundance of Cer-
PCho d18:0/18:0 (Fig. 3).
These results suggest that CerPCho may play an impor-
tant role in the development of pathological changes in the 
central nervous systems of neuroborreliosis patients. It has 
been shown that B. burgdorferi can induce an autoimmune 
attack on myelin sheaths, as glycolipid galactocerebroside, 
the major component of myelin, has structural similarities 
to the B. burgdorferi glycolipid antigen BbGL-2 [14]. The 
inflammatory demyelination of neurons, as well as periph-
eral nerves, in Lyme disease has been suggested in previous 
studies [15, 16]. We analyzed the relative abundances of 
major CerPCho species using PCA. There were some dif-
ferences in the clustering of samples from healthy volun-
teers and neuroborreliosis patients (Fig.S1 supplementary 
material), but these groups did not form distinct clusters.
Lysophosphatidylcholine
All of the most abundant LysoPtdCho species identified 
showed the tendency to increase in patients, with LysoPt-
dCho 16:0 and LysoPtdCho 18:2 significantly more abun-
dant in neuroborreliosis patients than in controls (Fig. 4).
It is well known that LysoPtdCho can be generated 
under physiological conditions by PLA2-mediated hydroly-
sis of PtdCho [17], or from the hydrolysis of oxidized Ptd-
Cho by PAF-acetylhydrolase [18]. Both mechanisms are 
possible, although previous work demonstrating increased 
lipid peroxidation in neuroborreliosis patients suggests 
that the latter mechanism may prevail [1]. LysoPtdCho 
are probably involved in demyelination [19], although, to 
date no substantiated data supporting LysoPtdCho-induced 
demyelination in Lyme disease has been published. PCA 
analysis of the major LysoPtdCho species completely dis-
tinguished between neuroborreliosis patients and healthy 
controls (Fig. S2, Supplementary Material).
Phosphatidylethanolamine and Phosphatidylinositol
PtdIns and PtdEtn (Figs. 5 and 6) were not significantly 
different between healthy subjects and neuroborreliosis 
patients.
Finally, we analyzed all the PL classes (PtdCho, LysoPt-
dCho, CerPCho, PtdEtn, and PtdIns) using PCA. The 
resulting plot (Fig. S3, Supplementary Material) revealed a 
good separation between healthy subjects and neuroborre-
liosis patients. This indicates that the plasma PL profiles of 
















































































Fig. 2  PtdCho molecular species relative compositions in healthy 
subjects and neuroborreliosis patients (values are mean ± SD). 
The PtdCho species are PtdCho 16:0/16:1, PtdCho 16:0/16:0, Ptd-
Cho 16:0/18:2, PtdCho 16:1/18:0, PtdCho 16:0/20:4, PtdCho 
18:1/18:2, PtdCho 18:0/18:2, and PtdCho 18:1/20:1, corresponding 
to [M + OAc]− at m/z 790.4854, 792.5748, 816.5764, 818.5904, 









































































































Fig. 3  CerPCho molecular species relative compositions in 
plasma of healthy subjects and neuroborreliosis patients (values 
are mean ± SD, *p < 0.05). The CerPCho species are CerPCho 
d18:1/14:0, CerPCho d18:1/16:0, CerPCho d18:0/16:0, CerPCho 
d18:1/18:1, CerPCho d18:0/18:1, CerPCho d18:1/18:0, CerPCho 
d18:0/18:0, CerPCho d18:1/20:0, CerPCho d18:1/22:1, CerPCho 
d18:1/22:0, and CerPCho d18:1/24:1, observed as [M + OAc]− ions 
at m/z 733.5508, 761.5823, 763.5879, 787.5974, 789.6128, 791.4909, 
817.6433, 843.5654, 845.6746, and 871.6906, respectively
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In conclusion, to our knowledge, this is the first report of 
differences in plasma PL classes and their molecular spe-
cies in neuroborreliosis patients and healthy subjects. Total 
PL quantification showed that the abundance of PtdCho in 
plasma is significantly lower in neuroborreliosis patients 
than in controls. However, the abundances of CerPCho and 
LysoPtdCho were significantly higher in these patients. 
HILIC-LC–MS data showed that the two most abundant 
lysophosphatidylcholines, LysoPtdCho 16:0 and LysoPt-
dCho 18:2, were significantly different between neurobor-
reliosis and controls; although, the relevance of this finding 
remains to be determined. Moreover, significant differ-
ences in the molecular composition of sphingomyelin pro-
files were also observed. The plasma of neuroborreliosis 
patients had a significantly higher relative abundance of 
CerPCho d18:1/24:1 and a lower relative abundance of 
CerPCho d18:0/18:0. These changes could be related to the 
evolution of the disease, including the occurrence of the 
demyelination process. PCA revealed a good separation of 
the relative abundances of all PL class species in healthy 
controls and neuroborreliosis patients with PC axes reveal-
ing almost complete distinction between them. Further 
studies are needed to clarify if these changes are specific 
to neuroborreliosis, and whether and how they are related 
to its pathogenesis. These results may be a useful starting 
point in defining potential PL neuroborreliosis biomarkers.
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Fig. 4  LysoPtdCho molecular species relative abundances in 
plasma of healthy subjects and neuroborreliosis patients (values are 
mean ± SD *p < 0.05 and ***p < 0.001). The LysoPtdCho spe-
cies are LysoPtdCho 16:1, LysoPtdCho 16:0, LysoPtdCho O-18:0, 
LysoPtdCho 18:2, LysoPtdCho 18:1, LysoPtdCho 18:0 and LysoPt-
dCho 20:1, corresponding to [M + OAc]− at m/z 552.331, 554.3472, 































































Fig. 5  The most abundant PtdIns molecular species relative abun-
dances in plasma of healthy subjects, neuroborreliosis and Lyme 
arthritis patients (values are mean ± SD). The PtdIns species 
are PtdIns 16:0/16:0, PtdIns 18:0/18:2, PtdIns 18:0/20:4, PtdIns 
18:0/20:3, PtdIns 18:3/22:0, PtdIns 18:2/23:0 and PtdIns 18:2/24:0, 
corresponding to [M-H]− at m/z 809.5136, 861.5501, 885.5502, 




















































































Fig. 6  The most abundant PtdEtn molecular species relative abun-
dances in plasma of healthy subjects, neuroborreliosis, and Lyme 
arthritis patients (values are mean ± SD). The PtdEtn species are 
PtdEtn 16:0/18:1, PtdEtn 16:1/20:4, PtdEtn 18:0/18:2, PtdEtn 
16:0/20:0, PtdEtn 16:0/22:6, PtdEtn 18:1/20:4, PtdEtn 18:0/20:4, 
PtdEtn 18:0/20:0, and PtdEtn 18:0/22:5, corresponding to [M-H]− 
at 716.4592, 738.5203, 742.5389, 746.5134, 762.5092, 764.5230, 
766.5394, 774.5443, and 792.4936, respectively
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